Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents
Eroglu I, Filippova OT, Kirrane M, Orpen M, Almonte V, Thomas R, Lee-Teh M, Tizon R, Sklarin N, O’Cearbhaill R. Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents. International Journal Of Gynecological Cancer 2022, 32: 1056-1062. PMID: 35675969, PMCID: PMC9924431, DOI: 10.1136/ijgc-2022-003466.Peer-Reviewed Original ResearchDesensitization protocolHypersensitivity reactionsInfusion timeAntineoplastic agentsCycles of therapyExtended infusion timeMedian infusion timePrior hypersensitivity reactionLeukotriene receptor antagonistsProgression of diseaseEligible patientsSuccessful desensitizationMedian ageRetrospective reviewColorectal cancerInpatient admissionsAntineoplastic therapyReceptor antagonistPatient outcomesLiposomal doxorubicinOvarian cancerMedian numberPatientsSpecific agentsDesensitization